Signant Health develops new program to work more closely with CROs

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Rawpixel)
(Image: Getty/Rawpixel)

Related tags Signant Health CRO eclinical

Signant Health’s new partner program was established to help reduce scope creep and prevent miscommunication between CROs and sponsors, says VP.

According to the company – formerly CRF Bracket​ – the new Signant Health Partner Program marks ‘a significant investment’ and the aim is to enable clinical research organizations (CROs) ‘to better serve sponsors,’ specifically as it pertains to patient data, patient experience, clinical supplies, and endpoint quality solutions.

“We are investing in people and streamlined processes to support CRO partners, such as increased training, scientific input, bid defense support, and ongoing governance of relationship,"​ explained Ken Billard, vice president of business development, Signant Health.

Billard added that the program was developed to strengthen the company’s CRO partnerships “to ultimately benefit sponsors.”  

Program partners will receive exclusive commercial terms, business development support, joint marketing, product training, and dedicated resources for governance, according to the company.

“Our goal is to work more closely with CROs to provide strategic planning, scientific insight, bid defense support, and comprehensive training on the Signant Health patient-centered eClinical platform to ensure our joint proposals are appropriately scoped and as comprehensive, scientifically sound, and efficient as possible,” ​Billard told us.

“By defining best practices with CROs covering the proposal process and ongoing delivery of services, we believe we can prevent miscommunication and reduce scope creep that is common when vendors work together,”​ he added.

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us

Products

View more

Webinars